<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00893828</url>
  </required_header>
  <id_info>
    <org_study_id>Rev. B, 29-Sep-08</org_study_id>
    <nct_id>NCT00893828</nct_id>
  </id_info>
  <brief_title>Monitoring Pulmonary Artery Pressure by Implantable Device Responding to Ultrasonic Signal (PAPIRUS III)</brief_title>
  <acronym>PAPIRUSIII</acronym>
  <official_title>Monitoring Pulmonary Artery Pressure by Implanted Device Responding to Ultrasonic Signal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The PAPIRUS III study will continue to follow patients initially enrolled in PAPIRUS II.&#xD;
      Pressure readings from the investigational device will continue to be collected and will be&#xD;
      correlated to physiological changes during activities of daily living and protocol defined&#xD;
      tests.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a small clinical trial to determine the feasibility of a device &amp; to test prototype&#xD;
      device, where the primary outcome measure relates to feasibility and not to health outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2009</start_date>
  <completion_date type="Actual">January 2017</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Continue detailed data collection of pressure readings from patients implanted with a RemonCHF device.</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <enrollment type="Actual">18</enrollment>
  <condition>Heart Failure</condition>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole Blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients previously implanted with a RemonCHF device&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient has been enrolled in the PAPIRUS II Study and has a RemonCHF pressure sensor&#xD;
             implanted&#xD;
&#xD;
          -  Patient is willing and able to provide informed consent, participate in the Safety&#xD;
             Follow-up Program and/or in the required tests associated with the clinical&#xD;
             investigation (Core Study Program) at an approved clinical investigational center and&#xD;
             at the intervals defined by the Clinical Investigational Plan.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient enrolled in PAPIRUS II but not implanted with a RemonCHF Pressure Sensor&#xD;
&#xD;
          -  Patients who are currently enrolled in another investigational study or registry that&#xD;
             would directly interfere with the current study (with the exception of the PAPIRUS II&#xD;
             Study). Each instance would be brought to the sponsor to determine eligibility.&#xD;
&#xD;
          -  Age &lt; 18 years&#xD;
&#xD;
          -  Women of childbearing potential who are, or might be, pregnant at the time of the&#xD;
             study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Uta C Hoppe, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cologne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Cologne</name>
      <address>
        <city>Cologne</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <study_first_submitted>May 5, 2009</study_first_submitted>
  <study_first_submitted_qc>May 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2009</study_first_posted>
  <last_update_submitted>February 16, 2017</last_update_submitted>
  <last_update_submitted_qc>February 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

